Goldline Pharmaceutical Limited

₹31.99As of Sun 8 Nov 2026, 12:00 UTC
BSE:544759Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 33.60%
Drugs, Drug Proprietaries, and Druggists' Sundries
Beta (5Y) —
PE TTM 5.361
TSR TTM —
Mkt cap ₹307.1M
ROIC 24.35%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹34
4.98%
132.47%
Hold 9|7|9|3|4
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.42
0.42
0.47
0.49
19.89%
14.74%
15.30%
15.87%
Revenue₹M
38.77
40.05
40.53
39.89
14.36%
15.16%
10.09%
4.26%
Peers (US$3.270M)
Cap (US$)
PE
2.724M
4.183x
Capital
TTM
5Y
10Y
Leveragex
0.503
0.027
—
EBIT/Intx
1.604
0.561
0.514
Own earn%
38.55
(22.79)
(25.19)
Sh yield%
18.53
30.57
32.04
Owners
Insiders/Inst%
12.53
42.53
Short interest%
1.72
SBC / revenue%
3.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
10–13
$1 testx
0.0
Incr. ROIC%
4